Literature DB >> 10993631

The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline.

T Theron1, A Binder, F Verheye-Dua, L Böhm.   

Abstract

PURPOSE: To examine the role of G2-block abrogation, DNA repair inhibition and apoptosis in the enhancement of radiotoxicity by pentoxifylline.
MATERIALS AND METHODS: The influence of pentoxifylline on radiotoxicity was assessed by colony assay in TP53 wild-type Bell and mutant MeWo melanoma, and in TP53 wild-type 4197 and mutant 4451 squamous cell carcinoma (SCC) cell lines. G2-block abrogation was assessed by flow cytometry. Induction of DNA damage and repair was measured over a dose range of 0-100 Gy by constant field gel electrophoresis (CFGE). The Annexin-V binding assay was used to identify apoptotic cells.
RESULTS: Pentoxifylline, when combined with irradiation, significantly increased radiotoxicity in the TP53 mutant MeWo and 4451 cell lines by radiotoxicity enhancement factors of 3 and 14.5 respectively. No radiosensitization was seen in the TP53 wild-type Be11 and 4197 cells. When the drug was added after irradiation at the time of maximum G2-block expression, no radiosensitization was seen in any of the four cell lines. CFGE analyses showed that pentoxifylline effectively suppressed DNA double-strand break (DSB) repair in all four cell lines, as indicated by 20 h repair inhibition factors of 1.4-2.4. Pentoxifylline did not increase apoptosis in any of the four cell lines.
CONCLUSION: These data suggest that radiosensitization by pentoxifylline is not a consequence of G2-block abrogation alone, but that inhibition of DSB repair plays a role in certain cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993631     DOI: 10.1080/09553000050134438

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  13 in total

1.  Influence of irradiation and pentoxifylline on histone H3 phosphorylation in human tumour cell lines.

Authors:  A Binder; L Bohm
Journal:  Cell Prolif       Date:  2002-02       Impact factor: 6.831

2.  Studies on the influence of DNA repair on radiosensitivity in prostate cell lines.

Authors:  Antonio M Serafin; John M Akudugu; Lothar Böhm
Journal:  Urol Res       Date:  2003-04-01

3.  G2-block after irradiation of cells with different p53 status.

Authors:  Friedo Zölzer; Ganesh Jagetia; Christian Streffer
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

4.  Pentoxifylline enhances the radioprotective properties of γ-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems.

Authors:  Maaike Berbée; Qiang Fu; Sarita Garg; Shilpa Kulkarni; K Sree Kumar; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2010-12-28       Impact factor: 2.841

5.  The effect of pentoxifylline on radiobiological parameters in the rat radiation myelopathy.

Authors:  Won Dong Kim; Woo Yoon Park
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

6.  Caffeine induces a second wave of apoptosis after low dose-rate gamma radiation of HL-60 cells.

Authors:  Jirina Vávrová; Martina Mareková-Rezácová; Doris Vokurková; Sylva Szkanderová; Jan Psutka
Journal:  Radiat Environ Biophys       Date:  2003-10-21       Impact factor: 1.925

7.  Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.

Authors:  Georgina Hernandez-Flores; Pablo C Ortiz-Lazareno; Jose Manuel Lerma-Diaz; Jorge R Dominguez-Rodriguez; Luis F Jave-Suarez; Adriana del C Aguilar-Lemarroy; Ruth de Celis-Carrillo; Susana del Toro-Arreola; Yessica C Castellanos-Esparza; Alejandro Bravo-Cuellar
Journal:  BMC Cancer       Date:  2011-11-10       Impact factor: 4.430

Review 8.  Inhibition of homologous recombination repair with Pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation.

Authors:  Lothar Bohm
Journal:  Radiat Oncol       Date:  2006-05-03       Impact factor: 3.481

9.  Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Authors:  Malgorzata Sztiller-Sikorska; Kamila Koprowska; Kinga Majchrzak; Mariusz Hartman; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

Review 10.  Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.

Authors:  Abhishek A Solanki; Stanley L Liauw
Journal:  Open Access J Urol       Date:  2011-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.